Synthetische Suchtstoffe der 2. Generation (sog. Designer Drugs) 1. Mitt.: Amphetamine und andere Arylalkanamine
- 1 January 1990
- journal article
- review article
- Published by Wiley in Pharmazie in unserer Zeit
- Vol. 19 (3) , 99-107
- https://doi.org/10.1002/pauz.19900190306
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Zur Bedeutung der Modellpsychosen* **Fortschritte der Neurologie · Psychiatrie, 1988
- Ichstörungen bei ModellpsychosenPublished by Springer Nature ,1988
- Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: EntactogensJournal of Psychoactive Drugs, 1986
- STPJournal of Psychedelic Drugs, 1977
- A Phenomenological Comparison of LSD and Schizophrenic StatesThe British Journal of Psychiatry, 1974
- Metabolism of amphetamines. Identification of N-oxygenated products by gas chromatography and mass spectrometryJournal of Pharmacy and Pharmacology, 1973
- The Early Symptoms of SchizophreniaThe British Journal of Psychiatry, 1966
- Metabolic fate of mescaline in manPsychopharmacology, 1966
- Die Experimentelle PsychosePublished by Springer Nature ,1962
- Ueber einige Derivate der Phenylmethacrylsäure und der PhenylisobuttersäureEuropean Journal of Inorganic Chemistry, 1887